APEI 3Q26 Earnings Call - AMERICAN PUBLIC EDUCATION INC

Explicit Guidance:

• Full Year 2026: Revenue raised to $695M–$701M (prior: $590M–$698M); Net income to $48.5M–$53.2M (prior: $46.5M–$52.5M); Adjusted EBITDA to $98M–$105M (prior: $96M–$104M); Diluted EPS to $2.59–$2.84 (prior: $2.48–$2.79); Capital expenditures lowered to $23M–$26M (prior: $25M–$28M).
• Fourth Quarter 2026: Revenue projected $179.4M–$185.4M; Net income $15.2M–$19.8M; Adjusted EBITDA $30.6M–$37.6M; Diluted EPS $0.81–$1.07.
• Operational Metrics for Q4 2026: Military Plus net course registrations forecast 100,000–105,000 (up 21.7%–27.7% YoY); Health Plus enrollments forecast ~20,100 (up ~1% YoY).
• Four-Year Long-Term Targets (FY2029): Revenue targeting $890M–$1B; Adjusted EBITDA margins targeting 20%–21%.

Business-Segment Outlook:

• Military Plus: Midpoint Q4 guidance reflects ~25% net course registration growth, driven by Army enrollment rebound and veteran/family growth; Q3 performance was muted by a $6M revenue shift into Q4.
• Health Plus: Revenue growth driven by low double-digit campus nursing growth (mix shift) and modest tuition increases in H2 2025; Online non-healthcare ("Online Plus") revenue identified as a weakness pulling down overall enrollment headwinds.
• Campus Expansion (Trailblazer Initiative): On track to open two new smaller footprint campuses annually for the next four years; new campuses targeted to reach cash-flow breakeven in 18 months and full utilization in 4–5 years.
• Specific Campus Timing: Orlando campus performing ahead of expectations (evening LPN program launched); Detroit Campus 2 delayed by one quarter (now targeting Q2 2027 start due to HLC accreditation); Waterdale campus on pace for Q4 2027 opening; South Florida (Fort Lauderdale) campus opening anticipated late 2028.
• Online Health: Online health programs identified as strong growth areas; "Online Plus" (non-healthcare online) expected to remain flat or decline slightly, with management evaluating marketing and differentiation strategies.

Market and Competitive Outlook:

• Demand Trends: Military Plus enrollment expected to rebound with active duty registrations returning to growth; demand for health professionals driving double-digit growth in campus nursing and online health; veteran/family registrations growing at double-digit rates.
• Pricing Strategy: Military Plus undergraduate active duty rates held at $250/credit (value proposition: no out-of-pocket); anticipated very small price increases in 2027 for veterans/families; Health Plus follows a cycle of price increases every other year with modest inflationary adjustments.
• Supply/Operations: Focus on "fill the back row" strategy with existing campuses to drive margin expansion; mix shift from online to campus nursing expected to double revenue per student.
• Structural Changes: Institutional combination now fully operational as a single Higher Learning Commission (HLC) accredited entity to simplify operations and enhance risk management.

Macro / Industry Outlook:

• Geopolitics: Full-year guidance does not assume resolution of the Middle East conflict; however, a resolution could support additional growth given the Army's student concentration; Q4 enrollment variability linked to potential deployment impacts.
• Regulatory/Government: NDAA status uncertain pending new election outcomes; Department of War evaluating tuition assistance changes (reimbursement levels for different classifications); no definitive information yet on per-credit hour funding changes for active duty.
• Federal Payment Timelines: Title IV disbursement delays post-combination expected to be temporary; bad debt expense anticipated to improve in Q4 as processing completes.
• Inflation: Management expects to mitigate rising faculty, clinical placement, and healthcare benefit costs via operational efficiencies and technology; employee compensation benefits anticipated to rise again in 2027.

Strategic Initiatives:

• Institutional Combination Synergies: Target $5M recurring cost savings in 2027 (Rasmussen + Hondros integration, including consolidated buying); Target $9M recurring savings in 2028 (HealthPlus + MilitaryPlus integration, including shared services).
• Technology (Student Lifecycle Platform): Implementation with Salesforce scheduled for early 2027 go-live with HealthPlus (student support/admissions); benefits (retention, lower cost-to-serve) expected as incremental upside to the published four-year plan.
• Marketing Optimization: End-to-end evaluation of marketing efficiency launched; improvements expected to continue into H1 2027 and beyond; increased S&P expenses in Q3 intentionally taken to support growth.
• M&A/Capital Allocation: Share repurchase program authorization $50M ($14M utilized YTD, $36M remaining); board focused on organic growth and technology as first priority before M&A; M&A opportunities monitored.
• Governance: Shira Goodman (ex-Staples CEO) joined board October 27, 2026, to leverage expertise in strategic growth.

Risks and Headwinds to Outlook:

• Revenue Timing: $6M revenue shift from Q3 to Q4 in 2026 could impact Q3 comparability.
• Regulatory & Policy: Potential changes to federal/state government policies, military tuition assistance reimbursement rates, and NDAA legislation.
• Operational/Systems: Delays in Title IV disbursements and financial aid packaging due to the institutional combination process (now resolving).
• Conflict Impact: Ongoing Middle East conflict and potential U.S. military deployments creating variability in Military Plus enrollment.
• Academic Accreditation: Accrual delays (e.g., Detroit Campus) due to transition from ABHES to HLC requiring separate location approvals.
• Market Volatility: Weakness in "Online Plus" (non-healthcare online) enrollment and potential inflationary pressure on clinical placement/faculty costs.
• Worst-Case Scenarios: Current bad debt estimates reflect a worst-case scenario regarding Title IV delays; management expects Q4 delivery to be better.

Management Tone on the Future:

• Confidence: High confidence in "strong moat" in Military Plus and Health Plus; described Q3 as a "very strong one" and confirmed "long-term strategy... is intact."
• Guidance Changes: Aggressive raising of full-year and Q4 guidance ranges, signaling strong momentum and belief in the combination's efficacy.
• Strategic Hedges: Management acknowledges uncertainty in Q4 registration ranges (wider than historical norms) due to "one month left" in start cycle and geopolitical variables; explicitly states they are "working to deliver a better number" for bad debt by Q4.
• Long-Term View: Reaffirmed $890M–$1B revenue target for 2029 and 20–21% EBITDA margin; emphasizes "organic and inorganic" growth framework.

Miscellaneous:

• Share Count: Weighted average diluted share count declined to 18.7M in Q3 from 18.8M in prior year due to accelerated buyback pace.
• Financial Position: Cash and short-term investments totaled $216.4M (up 22.6% YoY); excess cash over debt $128.7M; $40M available capacity under revolving credit facility.
• Cost Structure: Selling and promotion expenses increased to 24.7% of revenue (vs. 22.1% YoY) due to marketing optimization investments; G&A increased due to bad debt and professional services.
• Non-Healthcare Revenue: Online non-healthcare revenue growth was "muted" (low single digits), dragging down total APEI revenue growth to 3.6% despite strong segment performance.